IL-4 mRNA Is Downregulated in the Liver of Pancreatic Cancer Patients Suffering from Cachexia

References

• Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, et al.: Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12, 1193–1201, 2008. doi: 10.1007/s11605-008-0505-z
   PubMed Web of Science ®Google Scholar
• Tisdale MJ: Mechanisms of cancer cachexia. Physiol Rev 89, 381–410, 2009. doi: 10.1152/physrev.00016.2008
   PubMed Web of Science ®Google Scholar
• Pajak B, Orzechowska S, Pijet B, Pijet M, Pogorzelska A, et al.: Crossroads of cytokine signaling—the chase to stop muscle cachexia. J Physiol Pharmacol 59 (Suppl 9), 251–264, 2008.
   PubMed Web of Science ®Google Scholar
• Tan CR, Yaffee PM, Jamil LH, Lo SK, Nissen N, et al.: Pancreatic cancer cachexia: a review of mechanisms and therapeutics. Front Physiol 5, 88, 2014. doi: 10.3389/fphys.2014.00088
   PubMed Web of Science ®Google Scholar
• Argiles JM, Busquets S, Toledo M, and Lopez-Soriano FJ: The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care 3, 263–268, 2009. doi: 10.1097/SPC.0b013e3283311d09
   PubMedGoogle Scholar
• Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, et al.: The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PLoS One 7, e41883, 2012. doi: 10.1371/journal.pone.0041883
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhao C, Moya R, and Davies JD: A novel role for CD4+ T cells in the control of cachexia. J Immunol 181, 4676–4684, 2008.
   PubMed Web of Science ®Google Scholar
• Skorokhod A, Bachmann J, Giese N, Martignoni ME, and Krakowski-Roosen H: Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia. BMC Cancer 12, 265, 2012. doi: 10.1186/1471-2407-12-265
   PubMed Web of Science ®Google Scholar
• Bonetto A, Aydogdu T, Kunzevitzky N, Guttridge DC, Khuri S, et al.: STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS One 6, e22538, 2011. doi: 10.1371/journal.pone.0022538
   PubMed Web of Science ®Google Scholar
• Kelly-Welch A, Hanson EM, and Keegan AD: Interleukin-4 (IL-4) pathway. Sci STKE 2005, cm9, 2005. doi: 10.1126/stke.2932005cm9
   PubMedGoogle Scholar
• Prokopchuk O, Liu Y, Wang L, Wirth K, Schmidtbleicher D, et al.: Skeletal muscle IL-4, IL-4Ralpha, IL-13 and IL-13Ralpha1 expression and response to strength training. Exerc Immunol Rev 13, 67–75, 2007.
   PubMed Web of Science ®Google Scholar
• Prokopchuk O, Liu Y, Henne-Bruns D, and Kornmann M: Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Br J Cancer 92, 921–928, 2005. doi: 10.1038/sj.bjc.6602416
   PubMed Web of Science ®Google Scholar
• Hallett MA, Venmar KT, and Fingleton B: Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res 72, 6338–6343, 2012. doi: 10.1158/0008-5472.CAN-12-3544
   PubMed Web of Science ®Google Scholar
• Horsley V, Jansen KM, Mills ST, and Pavlath GK: IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483–494, 2003.
   PubMed Web of Science ®Google Scholar
• Stanya KJ, Jacobi D, Liu S, Bhargava P, Dai L, et al.: Direct control of hepatic glucose production by interleukin-13 in mice. J Clin Invest 123, 261–271, 2013. doi: 10.1172/JCI64941
   PubMed Web of Science ®Google Scholar
• Machado MV, Yang Y, and Diehl AM: The benefits of restraint: a pivotal role for IL-13 in hepatic glucose homeostasis. J Clin Invest 123, 115–117, 2013. doi: 10.1172/JCI67238
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Joshi B, Nakajima A, and Puri RK: A novel role of interleukin-13 receptor alpha2 in pancreatic cancer invasion and metastasis. Cancer Res 69, 8678–8685, 2009. doi: 10.1158/0008-5472.CAN-09-2100
   PubMed Web of Science ®Google Scholar
• Barderas R, Bartolome RA, Fernandez-Acenero MJ, Torres S, and Casal JI: High expression of IL-13 receptor alpha2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res 72, 2780–2790, 2012. doi: 10.1158/0008-5472.CAN-11-4090
   PubMed Web of Science ®Google Scholar
• Sturlan S, Beinhauer BG, Oberhuber G, Huang L, Aasen AO, et al.: In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice. Anticancer Res 22, 2547–2554, 2002.
   PubMed Web of Science ®Google Scholar
• Argiles JM, Stemmler B, Lopez-Soriano FJ, and Busquets S: Nonmuscle tissues contribution to cancer cachexia. Mediators Inflamm 2015, 182872, 2015. doi: 10.1155/2015/182872
   PubMed Web of Science ®Google Scholar
• Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, et al.: Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12, 489–495, 2011. doi: 10.1016/S1470-2045(10)70218-7
   PubMed Web of Science ®Google Scholar
• Bachmann J, Buchler MW, Friess H, and Martignoni ME: Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome. Nutr Cancer 65, 827–833, 2013. doi: 10.1080/01635581.2013.804580
   PubMed Web of Science ®Google Scholar
• Martignoni ME, Dimitriu C, Bachmann J, Krakowski-Rosen H, Ketterer K, et al.: Liver macrophages contribute to pancreatic cancer-related cachexia. Oncol Rep 21, 363–369, 2009.
   PubMed Web of Science ®Google Scholar
• Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, et al.: Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function. BMC Cancer 9, 255, 2009. doi: 10.1186/1471-2407-9-255
   PubMedGoogle Scholar
• Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408, 2001. doi: 10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Martignoni ME, Kunze P, Hildebrandt W, Kunzli B, Berberat P, et al.: Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clin Cancer Res 11, 5802–5808, 2005. doi: 10.1158/1078-0432.CCR-05-0185
   PubMed Web of Science ®Google Scholar
• Narsale AA, Enos RT, Puppa MJ, Chatterjee S, Murphy EA, et al.: Liver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression. PLoS One 10, e0119888, 2015. doi: 10.1371/journal.pone.0119888
   Web of Science ®Google Scholar
• Dumas JF, Goupille C, Julienne CM, Pinault M, Chevalier S, et al.: Efficiency of oxidative phosphorylation in liver mitochondria is decreased in a rat model of peritoneal carcinosis. J Hepatol 54, 320–327, 2011. doi: 10.1016/j.jhep.2010.08.012
   PubMed Web of Science ®Google Scholar
• Gilabert M, Calvo E, Airoldi A, Hamidi T, Moutardier V, et al.: Pancreatic cancer-induced cachexia is Jak2-dependent in mice. J Cell Physiol, 2014. doi: 10.1002/jcp.24580
   PubMed Web of Science ®Google Scholar
• Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, et al.: Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31, 1539–1547, 2013. doi: 10.1200/JCO.2012.45.2722
   PubMed Web of Science ®Google Scholar
• Fearon KC, Voss AC, Hustead DS, and Cancer Cachexia Study G: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83, 1345–1350, 2006.
   PubMed Web of Science ®Google Scholar
• Das SK, Eder S, Schauer S, Diwoky C, Temmel H, et al.: Adipose triglyceride lipase contributes to cancer-associated cachexia. Science 333, 233–238, 2011. doi: 10.1126/science.1198973
   PubMed Web of Science ®Google Scholar
• Battaglini CL, Hackney AC, and Goodwin ML: Cancer cachexia: muscle physiology and exercise training. Cancers (Basel) 4, 1247–1251, 2012. doi: 10.3390/cancers4041247
   PubMedGoogle Scholar